These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23991970)

  • 1. Biomarkers screening between preoperative and postoperative patients in pancreatic cancer.
    Li P; Yang J; Ma QY; Wu Z; Huang C; Li XQ; Wang Z
    Asian Pac J Cancer Prev; 2013; 14(7):4161-5. PubMed ID: 23991970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS.
    Yang J; Zhu J; He K; Zhao LY; Liu LY; Song TS; Huang C
    J Clin Lab Anal; 2015 Jul; 29(4):321-7. PubMed ID: 25130542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS.
    Xue A; Gandy RC; Chung L; Baxter RC; Smith RC
    Pancreatology; 2012; 12(2):124-9. PubMed ID: 22487522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-Binding Motif Protein 6 is a Candidate Serum Biomarker for Pancreatic Cancer.
    Duan B; Hu X; Fan M; Xiong X; Han L; Wang Z; Tong D; Liu L; Wang X; Li W; Yang J; Huang C
    Proteomics Clin Appl; 2019 Sep; 13(5):e1900048. PubMed ID: 31207145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SELDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of a boosting decision tree model for diagnosis of pancreatic cancer.
    Qian JY; Mou SH; Liu CB
    Asian Pac J Cancer Prev; 2012; 13(5):1911-5. PubMed ID: 22901146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
    Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
    Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
    Yang J; Yang J; Gao Y; Zhao L; Liu L; Qin Y; Wang X; Song T; Huang C
    PLoS One; 2014; 9(11):e111364. PubMed ID: 25368985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New serum biomarkers for detection of endometriosis using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Zheng N; Pan C; Liu W
    J Int Med Res; 2011; 39(4):1184-92. PubMed ID: 21986120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of serum diagnosis of pancreatic cancer by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Gao H; Zheng Z; Yue Z; Liu F; Zhou L; Zhao X
    Int J Mol Med; 2012 Nov; 30(5):1061-8. PubMed ID: 22941199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Small Proteins and Peptides in the Differentiation of Patients with Intraductal Mucinous Neoplasms of the Pancreas, Chronic Pancreatitis and Pancreatic Adenocarcinoma.
    Fania C; Pezzilli R; Melzi d'Eril G; Gelfi C; Barassi A
    Dig Dis Sci; 2018 Apr; 63(4):920-933. PubMed ID: 29417328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel serum peptides biomarkers for female breast cancer patients in Western China.
    Yang J; Xiong X; Liu S; Zhu J; Luo M; Liu L; Zhao L; Qin Y; Song T; Huang C
    Proteomics; 2016 Mar; 16(6):925-34. PubMed ID: 26705257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
    Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
    Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.
    Shevchenko VE; Arnotskaya NE; Zaridze DG
    Eur J Mass Spectrom (Chichester); 2010; 16(4):539-49. PubMed ID: 20625202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC).
    Yang J; Song YC; Song TS; Hu XY; Guo YM; Li ZF; Dang CX; Huang C
    J Clin Lab Anal; 2012 May; 26(3):148-54. PubMed ID: 22628229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminarily screening of serum characteristic markers in acute myeloid leukemia and clinical significance].
    He AL; Bai J; Huang C; Zhang WG; Yang J; Wang JL; Meng X; Tian W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1132-7. PubMed ID: 21129246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique].
    Ma N; Ge CL; Luan FM; Hu CJ; Li YZ; Liu YF
    Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):932-5. PubMed ID: 19035154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of serum biomarkers for occupational medicamentosa-like dermatitis induced by trichloroethylene using mass spectrometry.
    Hong WX; Liu W; Zhang Y; Huang P; Yang X; Ren X; Ye J; Huang H; Tang H; Zhou G; Huang X; Zhuang Z; Liu J
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):121-9. PubMed ID: 23994554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis.
    Guo J; Wang W; Liao P; Lou W; Ji Y; Zhang C; Wu J; Zhang S
    Cancer Sci; 2009 Dec; 100(12):2292-301. PubMed ID: 19775290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma.
    Chen J; Chen LJ; Xia YL; Zhou HC; Yang RB; Wu W; Lu Y; Hu LW; Zhao Y
    J Cancer Res Clin Oncol; 2013 Jul; 139(7):1117-27. PubMed ID: 23546595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.